Aerosol Delivery Devices Market 2023: Size, Share, Growth, Industry Trends and Forecast 2028
According to the latest report by IMARC Group, titled “Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Aerosol delivery devices are used to assist in the delivery of medications through inhalation. They are widely available as valved holder chambers, nebulizers, and dry powder, soft mist and smart inhalers. They aid in direct delivery to the treatment site, faster onset of drug action, and reducing systemic adverse while lowering the requirement of dosage as compared to systematic administration. As they provide painless and convenient treatment to patients, aerosol delivery devices are utilized to treat asthma, obstructive lung disease, pulmonary arterial hypertension, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/aerosol-delivery-devices-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
At present, the rising prevalence of respiratory diseases, such as pulmonary fibrosis, pneumonia, and lung cancer, among the masses represents one of the primary factors strengthening the market growth. Besides this, the wide availability of aerosol delivery devices through online and offline distribution channels, such as e-commerce platforms and retail and hospital pharmacies, is offering a positive market outlook. Apart from this, the increasing air pollution levels are deteriorating air quality and causing various lung diseases, which, in turn, is bolstering the growth of the market. Moreover, the rising awareness about improved healthcare facilities, along with the inflating income levels of individuals, is contributing to the growth of the market. Additionally, the increasing demand for aerosol delivery devices to treat non-respiratory diseases, such as diabetes, analgesia, thyroid, and genetic diseases, is offering lucrative growth opportunities to industry investors. Furthermore, key manufacturers are introducing mini ultrasonic nebulizers and inhalers with enhanced automatic memory, which is projected to propel the growth of the market.
Breakup by Product:
Dry Powder Inhalers
Single Dose Inhalers
Multi Dose Inhalers
Metered Dose Inhalers
Conventional Pressurized Inhalers
Soft Mist Inhalers
Nebulizers
Jet Nebulizers
Ultrasonic Wave Nebulizers
Vibrating Mesh Nebulizers
Breakup by Application:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis
Non-Respiratory Diseases
Diabetes
Analgesia
Parkinson’s Disease
Breakup by Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Stores
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
3M Company
Aerogen
GlaxoSmithKline plc
Johnson & Johnson
Koninklijke Philips N.V
Merck & Co. Inc
Metall Zug AG
Recipharm AB (publ)
Teva Pharmaceutical Industries Ltd
Vectura Group plc
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/aerosol-delivery-devices-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Other Reports:
Load Balancer Market Report: https://www.imarcgroup.com/load-balancer-market
Pen Needles Market Report: https://www.imarcgroup.com/pen-needles-market
Biosurgery Market Report: https://www.imarcgroup.com/biosurgery-market
Hair Weave Market Report: https://www.imarcgroup.com/hair-weave-market
Fermenters Market Report: https://www.imarcgroup.com/fermenters-market
Telecom Service Assurance Market Report: https://www.imarcgroup.com/telecom-service-assurance-market
Spa Market Report: https://www.imarcgroup.com/spa-market
Veterinary Infectious Disease Diagnostics Market Report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800